Medicine Description mellitofix 10mg
mellitofix effective in the treatment of type II diabetes is a medication that combines empagliflozin and metformin to manage blood glucose levels. Empagliflozin, a sodium-glucose co-transporter 2 (SGLT2) inhibitor, functions by blocking the reabsorption of glucose in the kidneys, leading to increased glucose excretion in the urine. This action lowers blood glucose levels effectively. Meanwhile, metformin enhances insulin sensitivity, decreases hepatic glucose production, and improves peripheral glucose uptake. Together, they create a synergistic effect that helps in achieving better glycemic control and may contribute to weight loss and cardiovascular health improvements.
Indications and Uses of mellitofix effective in the treatment of type II diabetes
- Management of type II diabetes mellitus
- Improvement of glycemic control in patients with type II diabetes
- Potential reduction in the risk of cardiovascular events based on empagliflozin's properties
Side Effects of mellitofix effective in the treatment of type II diabetes
- Nausea
- Diarrhea
- Abdominal pain
- Increased risk of urinary tract infections
- Hypoglycemia when used with other antidiabetic agents
- Dehydration
- Kidney function impairment
Storage and Handling
Store at room temperature, away from moisture and light. Keep out of reach of children.
Patient Advice and Precautions
Patients should remain hydrated while taking mellitofix, monitor blood glucose levels regularly, and consult healthcare professionals before combining with other medications. It is essential to inform healthcare providers about a history of kidney issues or urinary tract infections.